Portal Instruments

Portal Instruments designs injection systems for enhanced drug delivery, including PRIME, a needle-free injector for biologics, and PRIME Nexus, a reusable electronic injector compatible with standard prefilled syringes. Both platforms prioritise precision, patient comfort, and sustainability.
Headquarters
Portal Instruments Inc
190 5th Street
Cambridge
MA 02141
United States
Portal Instruments develops advanced injection devices for precise, connected, patient-friendly drug delivery.
Its portfolio includes the PRIME needle-free injector, delivering biologics rapidly without needles, and the PRIME Nexus re-usable electronic injector, designed for standard pre-filled syringes and viscosities up to 50 cP. Both platforms offer customisable injection settings and comprehensive connectivity via Bluetooth and Wi-Fi, enabling real-time adherence tracking and enhanced patient engagement. With this dual-platform approach, Portal addresses diverse therapeutic needs, emphasising precision, patient comfort, and sustainability.
Founded in 2012, Portal Instruments is privately held and backed by strategic investors and partnerships, including collaborations with leading pharmaceutical and medical device companies.